MAP2K7 and non-small cell lung carcinoma: The KRAS downstream molecules examined, except p-MEK and p-ERK, were also decreased in KRAS MT/p53 WT NSCLC cells, but neither in KRAS WT nor p53 MT NSCLC cells (Fig. 1E, and Suppl.